Previous Page  2 / 12 Next Page
Information
Show Menu
Previous Page 2 / 12 Next Page
Page Background

Tissue Science 2019

June 17-18, 2019

London, UK

Advances in Tissue

Engineering and

Biomaterials Science

13

th

Edition of International Conference on

Journal of Biomedical Sciences

ISSN: 2254-609X

Page 18

3D printing and electrospinning:

Applications in drug delivery and tissue

engineering

Dimitrios A. Lamprou

Queen’s University Belfast, UK

3D printing and electrospinning are example of

technologies that have been widely used in other

industries, however are new to Pharmaceutical

Industries and for Tissue Engineering Applications.

Therefore, the use of these techniques in drug delivery

and tissue engineering, including the use of state-

of-the-art characterisation methods (e.g. Bio-AFM,

ToF-SIMS, nanoCT) will discussed in this talk. The

first part will focus on the preparation of drug-loaded

polymeric electrospun nanofibers. The purpose of this

study is to examine any potential effects, chemical and

mechanically, of drug-loaded electrospun nanofiber

scaffolds. Biopolymers that used for biomedical

applications was loaded with either antibacterial

agents or broad-spectrum antibiotics. The electrospun

fibres were characterised through various methods

in order to measure the drug efficacy, antibacterial

properties, and drug-polymer interactions. There are

a number of different applications within medicine

that require materials to be developed with the

optimal characteristics, such as their strength, rate

of degradation, and porosity, as well as their shapes

and sizes. 3D printing process patented in 1986,

however only recently have be utilised in the field of

tissue Engineering using also bioprinters. Therefore,

in the second part, 3D printed systems that have be

formulated using advanced additive technologies

and characterised using advanced characterisation

techniques will be discussed.

Biography

Dimitrios Lamprou (Ph.D., MBA) is Reader in Pharmaceutical

Engineering and MSc Programme Director at the School of

Pharmacy in Queen’s University Belfast (UK; amember of the

Prestigious Russell Group) and Visiting Researcher at Univer-

sity of Strathclyde (Glasgow, UK) with experience of teaching

in Higher Education, conducting research (60+ publications,

200+ conference abstracts, 60+ Invited Presentations) and

securing national and international funding (£2M+). His

Group Research Interests focused on five distinct areas:

Biosurface Engineering, Electrospinning, Microfluidics, Nano-

analysis, and Printing of Medicines

d.lamprou@qub.ac.uk

Dimitrios A. Lamprou, J Biomedical Sci 2019, Volume 08